Viewing nowCombinationTops Tablets 40/10 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.

MFDS item code 201605612 · Approved 2016.09.22 · Insurance code 642905740
Treatment of essential hypertension not controlled with monotherapy
This medication is used as an effective treatment option for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy with either Telmisartan or Amlodipine. It helps to lower blood pressure steadily and reduces the risk of cardiovascular complications. The appropriate dosage and combination therapy are determined based on the individual patient's condition, and consistent use with regular blood pressure monitoring is essential. Additionally, it aids in blood pressure management when combined with lifestyle improvements. This medication effectively enhances blood pressure control in patients with challenging hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.
This medication can pose serious risks to the fetus when taken during pregnancy, especially in the second and third trimesters. It can lead to impaired kidney function, delayed skull formation, and in severe cases, even death, therefore it should not be used during pregnancy. This medication should not be administered to specific patients, including those allergic to the active ingredient or similar substances, pregnant women or those who may become pregnant, nursing mothers, and patients with severe liver or heart problems. Patients with impaired liver function or specific heart diseases, as well as those with severely compromised kidney function, should use this medication with increased caution, and dosage adjustment or close monitoring by healthcare professionals is required. Common side effects during treatment may include dizziness or swelling, while severe side effects such as fainting or heart issues may occur rarely. If unusual symptoms arise, immediate consultation with healthcare professionals is necessary. While taking this medication, hypotension may occur, so patients, especially those who are dehydrated or have low salt levels, should manage their condition effectively before use and seek appropriate measures if hypotension symptoms arise. This medication can increase potassium levels in the blood, so patients at risk for hyperkalemia should regularly check their potassium levels through blood tests. Patients with weakened kidney function should also have regular kidney function tests and blood tests while taking this medication. Safety for kidney transplant patients has not been established. In patients with heart diseases, the risk of angina or myocardial infarction may increase, thus they should be observant of any symptom changes while taking this medication. This medication may cause drowsiness or dizziness, necessitating caution while driving or operating hazardous machinery. Women planning a pregnancy or those who are pregnant should not take this medication and should immediately discontinue use and seek alternative treatment upon confirmation of pregnancy. This medication may interact with other drugs, therefore, it is crucial to inform healthcare providers about any other medications being taken, particularly when used concurrently with certain heart medications, diuretics, or potassium supplements. In case of overdose, hypotension, heart rate changes, kidney failure, etc., may occur, necessitating immediate medical attention. Store this medication out of reach of children, take it immediately after opening, and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, thus it should be stored in a light-blocking container. It is recommended to store it at room temperature between 1 to 30 degrees Celsius. Storing it this way will maintain the medication's efficacy and safety.
This medicine is a white and light blue, double convex, oval-shaped tablet.
30 tablets/box [10 tablets/Alu-Alu)x3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.